Therefore, the deciphering of the molecular clues of the mechanisms leading to MYC-mediated inhibition of p21, p27, and p15 functions or expression is critical for the design of therapeutic approaches of cancers with MYC deregulation. This evidence concerns the gene CDKN1B and cancer.